Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease

American Journal of Gastroenterology

Volumn 105, Issue 9, 2010, Pages 1934-1943

  Kandulski, Arne ^a   Wex, Thomas ^a   Mönkemüller, Klaus ^a   Kuester, Doerthe ^a   Fry, Lucia C ^a   Roessner, Albert ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; INTERLEUKIN 8; PROTEINASE ACTIVATED RECEPTOR 2; MESSENGER RNA;

ADULT; AGED; ARTICLE; BASAL CELL; CELL HYPERPLASIA; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HUMAN; INFLAMMATION; INTERCELLULAR SPACE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL; UPREGULATION; ADOLESCENT; ESOPHAGUS; GASTROINTESTINAL ENDOSCOPY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH MUCOSA;

ADOLESCENT; ADULT; AGED; CELL LINE; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGUS; FEMALE; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MALE; MIDDLE AGED; RECEPTOR, PAR-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 77956340005     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.265     Document Type: Article

References (36)

1. Ronkainen J, Aro P, Storskrubb T et al. High prevalence of gastroesophageal reflux symptoms and esophagitis withor without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005; 40: 275-285
2. Edebo A, Tam W, Bruno M et al. Magnification endoscopy for diagnosis of nonerosive reflux disease: a proposal of diagnostic criteria and critical analysis of observer variability. Endoscopy 2007; 39: 195-201
3. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report onobserver agreement. Gastroenterology 1996; 111: 85-92
4. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58: 163-174
5. Tobey NA, Carson JL, Alkiek RA et al. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 1996; 111: 1200-1205
6. Dent J. Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol 2007; 5: 4-16
7. Modlin IM, Hunt RH, Malfertheiner P et al. Diagnosis and management of non-erosive reflux disease\The Vevey NERD Consensus Group. Digestion 2009; 80: 74-88
8. Tack J. Review article: role of pepsin and bile in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005; 22 (Suppl 1): 48-54
9. Sifrim D, Mittal R, Fass R et al. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther 2007; 25: 1003-1017
10. Steinhoff M, Vergnolle N, Young SH et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000; 6: 151-158
11. Vergnolle N, Bunnett NW, Sharkey KA et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 2001; 7: 821-826
12. ScarboroughrM, Naughton MA, Teng W et al. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 1992; 267: 13146-13149
13. Dery O, Corvera CU, SteinhoffM et al. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998; 274 (6 Part 1): C1429-52
14. Yoshida N. Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr 2007; 40: 13-23
15. Yoshida N, Katada K, Handa O et al. Interleukin-8 production via proteaseactivated receptor 2 in human esophageal epithelial cells. Int J Mol Med 2007; 19: 335-340
16. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classificationof gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920
17. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validationof the Los Angeles classification. Gut 1999; 45: 172-180
18. Wex T, Treiber G, Lendeckel U et al. A two-step method for the extractionof high-quality RNA from endoscopic biopsies. Clin Chem Lab Med 2003; 41: 1033-1037
19. Vieth M, Fiocca R, Haringsma J et al. Radial distributionof dilated intercellular spaces of the esophageal squamous epithelium in patients withreflux disease exhibiting discrete endoscopic lesions. Dig Dis 2004; 22: 208-212
20. Monkemuller K, Wex T, Kuester D et al. Interleukin-1beta and interleukin-8 expression correlate with the histomorphological changes in esophageal mucosa of patients wiTherosive and non-erosive reflux disease. Digestion 2009; 79: 186-195
21. Wex T, Monkemuller K, Kuester D et al. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa. Eur J Gastroenterol Hepatol 2009; 21: 150-158
22. Inci K, Edebo A, Olbe L et al. Expressionof protease-activated-receptor 2 (PAR-2) in human esophageal mucosa. Scand J Gastroenterol 2009; 44: 664-671
23. Cottrell GS, Amadesi S, Schmidlin F et al. Protease-activated receptor 2: activation, signalling and function. Biochem Soc Trans 2003; 31 (Part 6): 1191-1197
24. DeFea KA, Zalevsky J, Thoma MS et al. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 2000; 148: 1267-1281
25. Vergnolle N, Hollenberg MD, Sharkey KA et al. Characterizationof the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 1999; 127: 1083-1090
26. Isomoto H, Wang A, Mizuta Y et al. Elevated levels of chemokines in esophageal mucosa of patients withreflux esophagitis. Am J Gastroenterol 2003; 98: 551-556
27. Isomoto H, Saenko VA, Kanazawa Y et al. Enhanced expressionof interleukin-8 and activationof nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol 2004; 99: 589-597
28. Mainie I, Tutuian R, Shay S et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-1402
29. Sifrim D, Castell D, Dent J et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-1031
30. Hak NG, Mostafa M, Salah T et al. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus. Hepatogastroenterology 2008; 55: 442-447
31. Monaco L, Brillantino A, Torelli F et al. Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors. World J Gastroenterol 2009; 15: 334-338
32. Farre R, van MH, De VR et al. Short exposure of oesophageal mucosa to bile acids, bothin acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 2008; 57: 1366-1374
33. Farre R, De VR, Geboes K et al. Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut 2007; 56: 1191-1197
34. Tobey NA, Hosseini SS, Argote CM et al. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 2004; 99: 13-22
35. Cenac N, Chin AC, Garcia-Villar R et al. PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and-independent pathways. J Physiol 2004; 558 (Part 3): 913-925
36. Jacob C, Yang PC, Darmoul D et al. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 2005; 280: 31936-31948.